- Home
- JSPR vs ORMP Comparison
JSPR vs ORMP Comparison
Compare JSPR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- ORMP
- Stock Information
- Founded
- JSPR 2018
- ORMP 2002
- Country
- JSPR United States
- ORMP United States
- Employees
- JSPR N/A
- ORMP N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- JSPR Health Care
- ORMP Health Care
- Exchange
- JSPR Nasdaq
- ORMP Nasdaq
- Market Cap
- JSPR 85.8M
- ORMP 84.3M
- IPO Year
- JSPR N/A
- ORMP N/A
- Fundamental
- Price
- JSPR $4.14
- ORMP $2.13
- Analyst Decision
- JSPR Strong Buy
- ORMP Hold
- Analyst Count
- JSPR 10
- ORMP 1
- Target Price
- JSPR $62.50
- ORMP N/A
- AVG Volume (30 Days)
- JSPR 216.1K
- ORMP 106.3K
- Earning Date
- JSPR 05-13-2025
- ORMP 03-27-2025
- Dividend Yield
- JSPR N/A
- ORMP N/A
- EPS Growth
- JSPR N/A
- ORMP N/A
- EPS
- JSPR N/A
- ORMP N/A
- Revenue
- JSPR N/A
- ORMP N/A
- Revenue This Year
- JSPR N/A
- ORMP N/A
- Revenue Next Year
- JSPR N/A
- ORMP N/A
- P/E Ratio
- JSPR N/A
- ORMP N/A
- Revenue Growth
- JSPR N/A
- ORMP N/A
- 52 Week Low
- JSPR $4.11
- ORMP $1.96
- 52 Week High
- JSPR $30.70
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- JSPR 26.71
- ORMP 37.77
- Support Level
- JSPR $5.11
- ORMP $2.32
- Resistance Level
- JSPR $5.53
- ORMP $2.40
- Average True Range (ATR)
- JSPR 0.33
- ORMP 0.09
- MACD
- JSPR -0.01
- ORMP -0.03
- Stochastic Oscillator
- JSPR 1.87
- ORMP 17.50
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.